| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/30/2001 | EP1102992A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 05/30/2001 | EP1102982A1 Surfaces with reduced electroosmotic flow |
| 05/30/2001 | EP1102977A1 Fluorescence assay for biological systems |
| 05/30/2001 | EP1102976A1 Multiple frequency fluorescence lifetime imaging |
| 05/30/2001 | EP1102865A2 Methods and compositions for modulating "marginally indiscriminant" hybridizations |
| 05/30/2001 | EP1102864A1 Gel microdrops in genetic analysis |
| 05/30/2001 | EP1102863A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 05/30/2001 | EP1102862A1 Antisense oligonucleotides targeted to il-15 |
| 05/30/2001 | EP1102858A2 Cell lines for the propagation of mutated herpes viruses |
| 05/30/2001 | EP1102857A2 Controlling starch synthesis |
| 05/30/2001 | EP1102856A1 Method of increasing the resistance of cultivated plants to phytopathogenic fungi and bacteria by methods of molecular genetics |
| 05/30/2001 | EP1102855A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 05/30/2001 | EP1102854A1 Method for increasing the resistance of cultivated plants to chemical stress |
| 05/30/2001 | EP1102853A1 N-acetylglycosaminyltransferase genes |
| 05/30/2001 | EP1102852A1 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
| 05/30/2001 | EP1102851A1 Recombinant poliovirus for the treatment of cancer |
| 05/30/2001 | EP1102850A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 05/30/2001 | EP1102849A2 A plant disease resistance signalling gene: materials and methods relating thereto |
| 05/30/2001 | EP1102848A2 Molecules designated ldcam |
| 05/30/2001 | EP1102847A2 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 05/30/2001 | EP1102846A1 Pancreatic and ovarian polypeptide, zsig58 |
| 05/30/2001 | EP1102845A1 Calcium/calmodulin dependent kinase and an alternative splice product thereof |
| 05/30/2001 | EP1102844A2 Human neuronal acid-sensitive cationic channel, its cloning and applications |
| 05/30/2001 | EP1102843A1 Nucleic sequences coding for an at2 interacting protein interacting with the at2 receptor and their applications |
| 05/30/2001 | EP1102842A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 05/30/2001 | EP1102841A2 Method for selective and optionally reversible degeneration of somatic plant tissue |
| 05/30/2001 | EP1102840A2 Transgenic animals having a modified glycoprotein v gene |
| 05/30/2001 | EP1102838A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 05/30/2001 | EP1102791A1 Modified green fluorescent protein |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | EP1102787A1 2'-o-aminoethyloxyethyl-modified oligonucleotides |
| 05/30/2001 | EP1102786A2 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
| 05/30/2001 | EP1102785A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES |
| 05/30/2001 | EP1102784A1 A compound containing a labile disulfide bond |
| 05/30/2001 | EP1102783A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
| 05/30/2001 | EP1102782A1 Structural analogs of amine bases and nucleosides |
| 05/30/2001 | EP1102775A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 05/30/2001 | EP1102596A1 Peptide antagonists of zonulin and methods for use of the same |
| 05/30/2001 | EP1102530A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes |
| 05/30/2001 | EP1102528A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
| 05/30/2001 | EP0920526A4 Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase |
| 05/30/2001 | EP0883699B1 Method and devices for the electrolytic formation of a deposit on an assembly of selected electrodes |
| 05/30/2001 | EP0721586B1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
| 05/30/2001 | EP0620822B1 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system |
| 05/30/2001 | CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents |
| 05/30/2001 | CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof |
| 05/30/2001 | CN1297529A Automated molecular pathology apparatus having independent slide heaters |
| 05/30/2001 | CN1297489A Method and apparatus for determination of length polymorphisms in DNA |
| 05/30/2001 | CN1297487A Fluorescence polarization screening method |
| 05/30/2001 | CN1297486A Anti-viral vectors |
| 05/30/2001 | CN1297485A i (streptomyces avermitilis) gene directing ratio of B2:B1 avermectins |
| 05/30/2001 | CN1297484A Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 05/30/2001 | CN1297483A Human protease and use of such protease for pharmaceutical applications and for reducing allergenicity of non-human proteins |
| 05/30/2001 | CN1297482A Group B streptococcus antigens |
| 05/30/2001 | CN1297481A Introduction of naked DNA or RNA encoding non-human vertebrate peptide hormones or cytokines into non-human vertebrate |
| 05/30/2001 | CN1297480A Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 05/30/2001 | CN1297479A Modified adenovirus contg. fiber replacement protein |
| 05/30/2001 | CN1297478A Compositions comprising viruses and methods for concentrating virus preparations |
| 05/30/2001 | CN1297477A Human spinal cord cell lines and methods of use therefor |
| 05/30/2001 | CN1297454A Novel omega-conotoxin peptides |
| 05/30/2001 | CN1297452A Modified factor VIII |
| 05/30/2001 | CN1297058A Detection of variation of nucleotide sequence by moving termination analysis |
| 05/30/2001 | CN1297055A New nucleotide sequence for coding pfk gene |
| 05/30/2001 | CN1297054A New nucleotide sequence for coding pfkA gene |
| 05/30/2001 | CN1297053A Polypeptide-human ubiquitin C-end hydrolase 28 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297051A Polypeptide-human phosphatase 79 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297050A Polypeptide-human phosphatidic acid phosphatase 2-35 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297049A Polypeptide-human cyclophosphate guanine suppressed phosphodiesterase 17 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297048A Polypeptide-human adenylylcyclase type V14 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297046A Polypeptide-human branched chain transacylase 31 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297045A Polypeptide-human UCT-isoenzyme 28 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1297043A Chinese bollworm virogenic engineering strain No.1 |
| 05/30/2001 | CN1296976A Polypeptide-human epidermal growth factor receptor protein 25 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296975A Polypeptide-human ribosomal protein L23 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296974A Polypeptide-human histone H2A.21 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296973A Polypeptide-human calbindin No.42 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296972A Polypeptide-human myosin heavy chain 74 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296971A Polypeptide-huntingtin protein interactive protein 65 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296970A Polypeptide-human actin-binding protein 54 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296969A Polypeptide-human X chromosome linked gene expression protein 14 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296968A Polypeptide-human karyon regulatory protein 56 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296967A Polypeptide-human deaf related gene 14 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296966A Polypeptide-human SR splicing factor 52 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296965A Polypeptide-human fibrous growth factor receptor 46 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296963A Polypeptide-human vascular epithelium cadherin 54 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296961A Polypeptide-human CDC4 analogous protein 13 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296960A Polypeptide-human CCR4 related protein 31 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296959A Polypeptide-human FD23 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296958A Polypeptide-human G protein 44 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1296955A Human susceptible protein and its coding sequence |
| 05/30/2001 | CN1296954A Human membrane protein containing C2 structural domain and its coding sequence |
| 05/30/2001 | CN1296953A Mycoplasma hyopnaumoniae (mhp) 3 gene nuclein and protein, and use thereof |
| 05/30/2001 | CN1296952A Polypeptide-complement receptor 222 and polynucleotide for coding said polypeptide |
| 05/30/2001 | CN1066488C Bioprocess for preparing 7-ADCA |
| 05/30/2001 | CN1066487C Gene identifying sterile plant cytoplasm and process for preparing hybrid plant by using same |
| 05/30/2001 | CN1066486C Riboflavinover producing strains of bacteria |
| 05/30/2001 | CN1066345C Growth hormone releasing factor analogs |
| 05/30/2001 | CN1066309C AHAS inhibiting herbicide resistant wheat selective mutation selecting method |